Showing results (3131-3140 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|December 27, 2005
Rasburicase: a new approach for preventing and/or treating tumor lysis syndromeOlga Bessmertny, Lauren M Robitaille, Mitchell S CairoCurrent Pharmaceutical Design|October 29, 2009
Characterization of MHC ligands for peptide based tumor vaccinationFelix Klug, Matthias Miller, Hans-Henning Schmidt, et al.Current Pharmaceutical Design|October 29, 2009
Use of MHC II structural features in the design of vaccines for organ-specific autoimmune diseasesAntonis K Moustakas, George K PapadopoulosCurrent Pharmaceutical Design|October 29, 2009
"Self-nonself" peptides in the design of vaccinesDarja KanducCurrent Pharmaceutical Design|October 29, 2009
Phosphodiesterase type 5 inhibitors for the management of erectile dysfunction: preference and adherence to treatmentT F Al-Shaiji, G B BrockCurrent Pharmaceutical Design|October 29, 2009
PDE5 inhibitors in non-urological conditionsC Vlachopoulos, D Terentes-Printzios, N Ioakeimidis, et al.Current Pharmaceutical Design|October 29, 2009
Role of calcitonin gene-related Peptide in gastric mucosal defence and healingS EvangelistaCurrent Pharmaceutical Design|October 29, 2009
Fibroblast growth factor-2 antagonist and antiangiogenic activity of long-pentraxin 3-derived synthetic peptidesD Leali, P Alessi, D Coltrini, et al.Current Pharmaceutical Design|November 21, 2009
Intra- and interdomain flexibility in matrix metalloproteinases: functional aspects and drug designIvano Bertini, Marco Fragai, Claudio LuchinatPageof 1,008